about
Differential expression of cholesterol hydroxylases in Alzheimer's diseaseA2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux.Regulation of foam cells by adenosine.Methotrexate in atherogenesis and cholesterol metabolismAdenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosisEffect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.Cholesterol 27-hydroxylase but not apolipoprotein apoE contributes to A2A adenosine receptor stimulated reverse cholesterol transportCholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.Construction of mutant and chimeric genes using the polymerase chain reactionCholesterol Metabolism in CKDEffect of inhibition of interleukin-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophagesPlasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular diseaseResveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages.Infliximab reverses suppression of cholesterol efflux proteins by TNF-α: a possible mechanism for modulation of atherogenesis.Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus.Resveratrol in cholesterol metabolism and atherosclerosis.Atherosclerosis and interferon-γ: new insights and therapeutic targetsPlasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on atherogenicity.Adenosine A(2A) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells.Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine.The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages.COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells.Statins in neurological disorders: mechanisms and therapeutic value.Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.Cholesterol 7-hydroxylase knockout mouse: a model for monohydroxy bile acid-related neonatal cholestasisRecent insights into the role of prostanoids in atherosclerotic vascular diseaseCholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAsOxytocin: Potential to mitigate cardiovascular riskMacrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin AAdenosine and the Cardiovascular System
P50
Q28262249-007E1D4C-BAD6-4B24-AD0C-7DFCD0917833Q33805277-04B44020-9AC4-40EC-AD85-E57BED70DC76Q34031160-F5800F3C-9DC4-461F-BE46-6FA0D3DFCC32Q34757801-47E00AAC-75A6-4116-867A-2FAF431CE9DAQ35546429-8C68BE33-CF19-4FD3-A8B8-8056AC30D722Q35769055-44A5351F-81E8-4D79-A072-C4ABFF79B7D9Q35784786-2D405800-313A-4DEA-A0D3-885D76D4CA95Q35814728-FC64AA38-785F-44FD-9A65-E55006E50DC6Q35862419-AA294535-2120-4DBB-9060-1F9BD5791A41Q36315574-60A8006C-25C9-4DA7-8EF6-79168102325AQ36387222-2ACB359C-E395-4DC0-93F7-163258B9C4A2Q37078045-B7A309C7-1838-4436-8F23-FAD13C1A74BDQ37197627-514DC102-6F99-4E74-9367-5C3C87164136Q37413355-CDE2FA03-F865-4F37-9B4C-E4FDFC892A26Q37577348-966940ED-3FDF-454A-96F9-812301C1E1A2Q37582576-69C8D532-87FE-4150-8B20-0711F325E39CQ38031542-86A644D8-B589-4661-94D7-10815BF9FBB0Q38126725-9F6F7653-3293-44E7-AA9F-89387B29C727Q38907279-F8B464EF-2830-442C-B8FD-03CDB243DB6FQ39241683-B0077217-971D-43AD-BCC1-F719AF39D5A3Q39264936-63424474-C6A1-4074-B07F-BB8FF918A695Q41703365-564118AC-C592-4CB0-9D65-EFA3E5E91F62Q44936644-0CD2259B-1456-40B4-B5AB-D320741EA30AQ50550764-154A9A7D-EAD8-4E41-89EB-7B1EFA993433Q53305494-DA5EE57D-9265-4C1A-BEB4-61FD4BF5F62FQ54590343-E8D98569-EF29-448C-A68E-F4D735E38315Q77494273-36E86B9E-74B7-4A14-995B-0F1A612D6086Q79315968-4E2118EA-0BB4-4917-9D69-9A566155F613Q92086227-C03FBD38-4ECB-48BD-8560-28322245EF85Q92189798-7EF0776A-3063-46B3-B155-715C143271D4Q92949163-3A6C9BB0-7ED8-46A4-8FFE-C3F37A463128Q93017208-4577B9C4-10D4-41AB-87F8-DE9877D53BC1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Allison B. Reiss
@ast
Allison B. Reiss
@en
Allison B. Reiss
@es
Allison B. Reiss
@nl
type
label
Allison B. Reiss
@ast
Allison B. Reiss
@en
Allison B. Reiss
@es
Allison B. Reiss
@nl
prefLabel
Allison B. Reiss
@ast
Allison B. Reiss
@en
Allison B. Reiss
@es
Allison B. Reiss
@nl
P108
P106
P1153
7102359263
P21
P31
P496
0000-0002-4478-2441